Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03950050
Recruitment Status : Recruiting
First Posted : May 15, 2019
Last Update Posted : September 24, 2019
Sponsor:
Information provided by (Responsible Party):
Shaare Zedek Medical Center